OncoDaily

Neil Ranasinghe: Surviving Childhood Cancer in Gaza - A Parent’s and a Doctor’s View from the SIOP Congress - OncoDaily Neil Ranasinghe: Surviving Childhood Cancer in Gaza - A Parent’s and a Doctor’s View from the SIOP Congress / Abu Sidhanee, cancer, Childhood Cancer, Children

Surviving Childhood Cancer in Gaza: A Parent’s and a Doctor’s View from the SIOP Congress - Neil Ranasinghe

@neil-r.bsky.social

oncodaily.com/voices/gaza-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Narjust Florez: Honored to Serve as the Discussant for Two Outstanding Junior Investigators at NACLC25 - OncoDaily Narjust Florez: Honored to Serve as the Discussant for Two Outstanding Junior Investigators at NACLC25 / cancer, NACLC25, Narjust Florez, OncoDaily, Oncology,

Honored to Serve as the Discussant for Two Outstanding Junior Investigators at NACLC25 - Narjust Florez

@narjustflorezmd.bsky.social

oncodaily.com/voices/narju...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Stephen V Liu: Presenting an Update on the Phase II eNRGy Trial at NACLC 2025 - OncoDaily Stephen V Liu: Presenting an Update on the Phase II eNRGy Trial at NACLC 2025 / FDA, NACLC 2025, NACLC25, NSCLC, Pancreatic Cancer, Stephen V Liu, zenocutuzumab

Presenting an Update on the Phase II eNRGy Trial at NACLC 2025 - Stephen V Liu

@stephenvliu.bsky.social

oncodaily.com/voices/steph...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Katya Losk: Dana-Farber Cancer Institute Was Delighted to Host Prof. Eli Sprecher - OncoDaily Katya Losk: Dana-Farber Cancer Institute Was Delighted to Host Prof. Eli Sprecher / cancer, Craig A Bunnell, Craig Bunnell, Dana-Farber Cancer Institute, Eli

Dana-Farber Cancer Institute Was Delighted to Host Prof. Eli Sprecher - Katya Losk

@danafarber.bsky.social @danafarbernews.bsky.social

oncodaily.com/voices/katya...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Natera Acquires Foresight Diagnostics - OncoDaily Natera Acquires Foresight Diagnostics / Adham Jurdi, cancer, Diffuse Large B-Cell Lymphoma, Foresight Diagnostics, Headlines, Natera, OncoDaily, Oncology,

Natera Acquires Foresight Diagnostics

oncodaily.com/voices/fores...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Natera #ForesightDiagnostics

Peri-operative Tislelizumab + Neoadjuvant Chemotherapy in Resectable NSCLC: Final RATIONALE-315 Results - OncoDaily Peri-operative tislelizumab plus platinum chemotherapy significantly improved OS, EFS, and pathological response in resectable stage II–IIIA NSCLC in RATIONALE-315.

Peri-operative Tislelizumab + Neoadjuvant Chemotherapy in Resectable NSCLC: Final RATIONALE-315 Results

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Digital Care Records Free Up Millions of Hours for UK Carers - OncoDaily Digital Care Records Free Up Millions of Hours for UK Carers / cancer, Global news, Headlines, Healhtcare news, OncoDaily, Oncology, UK, UK health, UK

Digital Care Records Free Up Millions of Hours for UK Carers

oncodaily.com/opinion/uk_h...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Top 10 OncoGrants of the Week: Driving Real-World Progress in Cancer Science, Care Delivery, and Workforce Capability - OncoDaily Top 10 OncoGrants of the Week: Driving Real-World Progress in Cancer Science, Care Delivery, and Workforce Capability / AI in healthcare, cancer grants,

Top 10 OncoGrants of the Week: Driving Real-World Progress in Cancer Science, Care Delivery, and Workforce Capability

oncodaily.com/voices/423477

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #OncoGrants

15 Posts Not to Miss from ASH 2025, Part 1 - OncoDaily 15 Posts Not to Miss from ASH 2025, Part 1 / Amer Zeidan MBBS, ASH, ASH2025, cancer, Charles Gaulin, Daniel Auclair, Dr. Pat Soon-Shiong, FACP, Headlines,

15 Posts Not to Miss from ASH 2025, Part 1

@ash.hematology.org

oncodaily.com/not-to-miss/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ASH #ASH25 #ASH2025

Oncology This Week: OncoDaily Weekly Dec 1-7 - OncoDaily Oncology This Week: OncoDaily Weekly Dec 1-7 / 10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors, 10 most promising drugs, 10th Anniversary Liquid

Oncology This Week: OncoDaily Weekly Dec 1-7

oncodaily.com/not-to-miss/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Medical Doctor Fellowship Opportunity with the RECIST Working Group at EORTC - OncoDaily Medical Doctor Fellowship Opportunity with the RECIST Working Group at EORTC / cancer, EORTC, OncoDaily, Oncology, RECIST Working Group

Medical Doctor Fellowship Opportunity with the RECIST Working Group at EORTC

@eortc.org

oncodaily.com/voices/docto...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EORTC #RECIST

Herbert Loong: Discussing Potentials and Implications of AI Driven Biomarkers in Oncology Clinical Care at ESMO Asia 2025 - OncoDaily Herbert Loong: Discussing Potentials and Implications of AI Driven Biomarkers in Oncology Clinical Care at ESMO Asia 2025 / A Prelaj, A. Marra, A. Pellat, A.

Discussing Potentials and Implications of AI-Driven Biomarkers in Oncology Clinical Care at ESMO Asia 2025 - Herbert Loong

@herbloongmd.bsky.social
@myesmo.bsky.social

oncodaily.com/voices/herbe...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMOAsia25 #ESMOAsia2025

Emily Drake: New Protocol for Conducting an Environmental Scan in Pediatric Oncology - OncoDaily Emily Drake: New Protocol for Conducting an Environmental Scan in Pediatric Oncology / Angelina Lui, Argerie Tsimicalis, cancer, Chiquita R. Hessels, Dilek

New Protocol for Conducting an Environmental Scan in Pediatric Oncology - Emily Drake

@ekdrake.bsky.social

oncodaily.com/voices/emily...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

AACR Announces 2025 Breast Cancer Research Award Recipients Ahead of SABCS 2025 - OncoDaily AACR Announces 2025 Breast Cancer Research Award Recipients Ahead of SABCS 2025 / AACR, Breast Cancer, OncoDaily, onoclogy, SABCS 2025

AACR Announces 2025 Breast Cancer Research Award Recipients Ahead of SABCS 2025

@theaacr.bsky.social
@sabcs.bsky.social
@stolaney1.bsky.social

oncodaily.com/industry/aac...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR #BreastCancer #SABCS #SABCS2025

Vincent Rajkumar: 20 Years, 20 FDA Approvals for Relapsed Myeloma - OncoDaily Vincent Rajkumar: 20 Years, 20 FDA Approvals for Relapsed Myeloma / cancer, FDA, multiple myeloma, Myeloma, OncoDaily, Oncology, Vincent Rajkumar

20 Years, 20 FDA Approvals for Relapsed Myeloma - Vincent Rajkumar

@vincentrk.bsky.social
@fda.gov

oncodaily.com/voices/fda-a...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #FDA #Myeloma #MM

Inside ESMO Asia 2025 with Angela Lamarca - OncoDaily Inside ESMO Asia 2025 with Angela Lamarca / Angela Lamarca, cancer, ESMO, ESMO Asia, ESMO Asia 2025, ESMO Asia 25, ESMOAsia25, Fabrice Andre, OncoDaily,

Inside ESMO Asia 2025 with Angela Lamarca

@myesmo.bsky.social

oncodaily.com/voices/esmo-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMOAsia #ESMOAsia25 #ESMOAsia2025

Inside ESMO Asia 2025 with David Planchard - OncoDaily Inside ESMO Asia 2025 with David Planchard / cancer, David Planchard, ESMO, ESMO Asia 2025, ESMO Asia 25, ESMOAsia25, OncoDaily, Oncology

Inside ESMO Asia 2025 with David Planchard

@myesmo.bsky.social

oncodaily.com/voices/esmo-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMOAsia #ESMOAsia25 #ESMOAsia2025

Radiotherapy for Lymphoma: Types, Success Rate, Side Effects And More - OncoDaily Radiotherapy for Lymphoma: Types, Success Rate, Side Effects And More / cancer, OncoDaily, Oncology, radiation oncology, radiotherapy, Radiotherapy for Lymphoma

Radiotherapy for Lymphoma: Types, Success Rate, Side Effects And More

oncodaily.com/opinion/radi...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Radiotherapy #Lymphoma

We’re Not Done Fighting for Ostomates - Fight Colorectal Cancer - OncoDaily We’re Not Done Fighting for Ostomates - Fight Colorectal Cancer / cancer, colorectal cancer, Fight Colorectal Cancer, OncoDaily, Oncology, ostomates, The

Fight Colorectal Cancer - We’re Not Done Fighting for Ostomates

@fightcrc.bsky.social

oncodaily.com/voices/fight...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #CRC #ColorectalCancer

Inside ESMO Asia 2025 with Deborah Mukherji - OncoDaily Inside ESMO Asia 2025 with Deborah Mukherji / cancer, Deborah Mukherji, ESMO, ESMO Asia 2025, ESMOAsia2025, ESMOAsia25, OncoDaily, Oncology

Inside ESMO Asia 2025 with Deborah Mukherji

@dmukherji.bsky.social
@myesmo.bsky.social

oncodaily.com/voices/esmo-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMOAsia #ESMOAsia25 #ESMOAsia2025

Yüksel Ürün: ASCO LDP is One of ASCO’s Best - OncoDaily Yüksel Ürün: ASCO LDP is One of ASCO’s Best / ASCO, ASCO LDP, cancer, Leadership Development Program, OncoDaily, Oncology, Yüksel Ürün

ASCO LDP is One of ASCO’s Best - Yüksel Ürün

@yukselurun.bsky.social
@ascocancer.bsky.social

oncodaily.com/voices/asco-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Olubukola Ayodele: Honoured to Receive Breast Cancer Now Grant for INTENSITY Project - OncoDaily Olubukola Ayodele: Honoured to Receive Breast Cancer Now Grant for INTENSITY Project / Breast Cancer, Breast Cancer Now, cancer, Olubukola Ayodele, OncoDaily,

Honoured to Receive Breast Cancer Now Grant for INTENSITY Project - Olubukola Ayodele

@bookiephronesis.bsky.social
@breastcancernow.bsky.social

oncodaily.com/career/olubu...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

AACRevol25 Cochair Welcomed Attendees to the AACR Conference on Cancer Evolution - OncoDaily AACRevol25 Cochair Welcomed Attendees to the AACR Conference on Cancer Evolution / AACR, AACR Conference on Cancer Evolution, AACRevol25, American Association

AACRevol25 Cochair Welcomed Attendees to the AACR Conference on Cancer Evolution

@theaacr.bsky.social @marasherman.bsky.social

oncodaily.com/voices/aacre...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Key Results from the ESO-Shanghai 17 and 9 Trials: Small T-Field Postoperative ChemoRT Shows Safer Profile in Resected ESCC - OncoDaily ESO-Shanghai 17: a 50.4 Gy small T-field matches ESO-9 outcomes while reducing toxicity and pneumonitis risk.

Key Results from the ESO-Shanghai 17 and 9 Trials: Small T-Field Postoperative ChemoRT Shows Safer Profile in Resected ESCC

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Bernard A. Fox: Myriam Chalabi Takes Cancer Immunotherapy Beyond MSI High - OncoDaily Bernard A. Fox: Myriam Chalabi Takes Cancer Immunotherapy Beyond MSI High / Agenus, Bernard A. Fox, cancer, colon cancers, immunotherapy, Myriam Chalabi,

Myriam Chalabi Takes Cancer Immunotherapy Beyond MSI High - Bernard A. Fox

@bernardafox.bsky.social

oncodaily.com/voices/berna...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

FDA to Shift Toward Single-Study Requirement for Drug and Medical Product Approvals - OncoDaily FDA to Shift Toward Single-Study Requirement for Drug and Medical Product Approvals / cancer, Drugmakers, FDA, Marty Makary, OncoDaily, Oncology, STAT, trials

FDA to Shift Toward Single-Study Requirement for Drug and Medical Product Approvals

@fda.gov

oncodaily.com/industry/fda-4

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #FDA

FDA Approves Lisocabtagene Maraleucel for Relapsed/Refractory Marginal Zone Lymphoma - OncoDaily FDA approves lisocabtagene maraleucel for relapsed/refractory marginal zone lymphoma based on TRANSCEND FL-MZL trial, offering a new CAR-T option.

FDA Approves Lisocabtagene Maraleucel for Relapsed/Refractory Marginal Zone Lymphoma

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Bill Gates on Reversing the Rising Tide of Global Child Mortality - OncoDaily Bill Gates on Reversing the Rising Tide of Global Child Mortality / Bill Gates, canecr, Global Child Mortality, Headlines, HIV, Next-Generation Maternal

Bill Gates on Reversing the Rising Tide of Global Child Mortality

@billgates.bsky.social

oncodaily.com/industry/bil...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Reveal Genomics has Signed a €2M Strategic Agreement with Avançsa - OncoDaily Reveal Genomics has Signed a €2M Strategic Agreement with Avançsa / Aleix Prat, Avançsa, cancer, Headlines, OncoDaily, Oncology, Precision Oncology, Reveal

Reveal Genomics has Signed a €2M Strategic Agreement with Avançsa

oncodaily.com/voices/revea...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily - OncoDaily 10 most promising cancer drugs not yet approved in 2025. See how early data in hard-to-treat cancers may reshape tomorrow’s oncology standards.

10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews